医疗保健服务利用率和过量药物死亡:国家嵌套病例控制注册研究研究
Linn Gjersing1,2, Ellen J Amundsen1
1Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway.
The American journal on addictions
|August 26, 2024
概括
处于药物过量风险的个人经常获得医疗保健服务,特别是全科医生 (GPs). 低社会经济地位和特定的诊断与过量服用死亡有关,突出了针对性预防措施的需要.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 识别处于药物过量风险的个体对于实施预防措施至关重要.
- 了解过去的医疗服务利用情况可以为有针对性的干预提供信息.
研究的目的:
- 为了检查因药物过量死亡的个人过去12个月的医疗服务使用情况.
- 为了确定最频繁使用的卫生服务.
- 为了探索过量死亡的相关性.
主要方法:
- 在挪威 (2010-2018) 基于人口的嵌套病例控制登记册研究 (2010-2018).
- 包括所有药物过量死亡 (n=2388) 和匹配的对照 (n=21,465).
- 与国家人口和患者登记册相关的数据;使用多变量条件后勤回归.
主要成果:
- 与对照组相比,过量服用病例使用的医疗服务的中位数较高 (3对1).
- 最常使用的服务是全科医生 (GP) 服务.
- 与过量服用死亡相关的因素包括低社会经济地位,心理和某些身体诊断,以及频繁的GP遭遇.
结论:
- 由于过量服用而死亡的个体的医疗服务利用率明显较高,全科医生是最常见的接触点.
- 低社会经济地位,特定的健康诊断和频繁的初级保健使用与过量死亡相关.
- 这些发现强调了医疗保健系统识别和干预风险人群的潜力.
相关概念视频
Pharmacovigilance
795
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
795
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
146
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
146
Prescription, Nonprescription and Orphan Drugs
706
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
706
Analysis of Population Pharmacokinetic Data
241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241
Hazard Ratio
103
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
103


